Does Zepbound Make You Tired? What Labels Say

Does Zepbound make you tired? It can. The Zepbound label lists fatigue at 5% to 7% of people on tirzepatide, against 3% on placebo, and the Wegovy label lists it at 11% against 5%. None of the four labels states how long fatigue lasts, so tiredness that lingers is a question for your prescriber.

In short

• The Zepbound label reports fatigue in 5%, 6% and 7% of people at 5, 10 and 15 mg, against 3% on placebo.
• The Wegovy label reports fatigue in 11% of people on 2.4 mg, against 5% on placebo.
• The Mounjaro and Ozempic labels do not list fatigue in their main adverse-reaction tables, so neither gives a comparable rate.

Does Zepbound or Mounjaro make you tired?

Fatigue is a listed adverse reaction of Zepbound, and the label names it among the reactions reported in at least 5% of patients, alongside nausea, diarrhea, vomiting and constipation. Mounjaro contains the same medicine, tirzepatide, but its label treats fatigue differently.

The Mounjaro label's main table for type 2 diabetes does not include fatigue. It appears only in the cardiovascular outcomes trial text, where the label reports 10% of Mounjaro-treated patients with it and gives no placebo figure. That absence is a gap in the label, not proof that tiredness never happens.

How common is fatigue by medicine, according to each label?

Each label reports fatigue differently, and only Zepbound and Wegovy give a rate against placebo. The table shows what each states.

The Zepbound figure counts asthenia, lethargy and malaise with fatigue. The gap over placebo is 2 points at 5 mg (5 minus 3) and 4 points at 15 mg (7 minus 3). For Wegovy it is 6 points (11 minus 5).

Do not rank the medicines from this table. The trials differ in population, dose and design, and the labels do not compare them head to head.

Why does a GLP-1 medicine cause fatigue?

The labels report fatigue as an adverse reaction but do not state a mechanism, so the cause is not established by these sources. What follows is our reasoning, not a label finding.

The Zepbound label lists nausea, vomiting, diarrhea and constipation among its common reactions. Eating less and losing fluid to vomiting or diarrhea can leave anyone tired. Whether that explains the fatigue in the trials is not shown.

A second possibility is low blood sugar. The Zepbound label says the medicine "lowers blood glucose and can cause hypoglycemia." The Wegovy label says the same. Causes unrelated to the medicine can also overlap, which a prescriber can look at.

How long does fatigue last after starting or increasing the dose?

No label gives a start, peak or end time for fatigue, so any exact duration you read elsewhere is not backed by these sources.

The Zepbound figures do show a pattern by dose: 5% at 5 mg, 6% at 10 mg and 7% at 15 mg. Higher doses had higher reported rates in the trials. That is a group comparison and does not tell you what happens to one person after a dose step.

Whether fatigue improves over time on semaglutide is also not stated on the Wegovy or Ozempic labels. A diary showing when tiredness began, relative to your dose dates, is something you can show your prescriber. The half-life calculator estimates how much semaglutide or tirzepatide your recent doses may leave in your body, so you can see where you are in your own schedule. Dose decisions stay with your prescriber.

What helps with fatigue on a GLP-1 medicine?

The labels do not list a fatigue remedy, so these steps rest on what the labels do say plus basic reasoning.

• Watch for low blood sugar symptoms. The Zepbound, Wegovy, Mounjaro and Ozempic labels all warn about hypoglycemia, so shakiness, sweating or confusion alongside tiredness is worth noting.
• Tell your prescriber what else you take. The Mounjaro and Ozempic labels say insulin or a sulfonylurea may raise the risk of hypoglycemia, including severe hypoglycemia.
• Note stomach symptoms. The Zepbound label lists nausea, vomiting and diarrhea as common, and fluid loss from them can add to tiredness. This is our reasoning, not a label claim. The next section covers the label's dehydration warning.
• Write down when tiredness happens. Record it next to dose days, meals and water so a pattern can be seen.
• Talk to your prescriber if it does not ease. Only they can decide whether anything about your treatment should change.

When is tiredness a warning sign that needs a doctor?

The labels' hypoglycemia and kidney warnings are what turn tiredness into a reason to contact a prescriber. The labels warn these medicines can cause hypoglycemia, with higher risk alongside insulin or a sulfonylurea.

• Zepbound: 4.2% against 1.3% on placebo in people with type 2 diabetes (Study 2).
• Wegovy: 6.2% against 2.5% on placebo in people with type 2 diabetes and a BMI of 27 or more.
• Ozempic with a sulfonylurea: 17.3% at 0.5 mg and 24.4% at 1 mg. With basal insulin: 15.2% on placebo, 16.7% at 0.5 mg and 29.8% at 1 mg.
• Mounjaro: more frequent hypoglycemia when combined with a sulfonylurea; the label gives no single rate here.
• Dehydration and kidney trouble: the labels warn of acute kidney injury, mostly after vomiting or diarrhea has led to dehydration. Signs to watch are persistent vomiting or diarrhea, very little urine, or tiredness that worsens with ongoing stomach symptoms.

Contact your prescriber about shakiness, sweating, confusion or faintness with tiredness, or about any dehydration sign above. As general advice rather than a label threshold, seek emergency care for fainting, severe confusion or sudden severe symptoms.

Where can you log fatigue next to your doses?

Dose & Lose is a tracking app that lets you rate fatigue from 0 to 10 each day and see it over time beside your logged doses. It also logs protein and water, so a pattern can be shown to a prescriber.

The app does not measure blood sugar, diagnose anything or give medical advice. See the Dose & Lose app, and open the free tools hub to use the half-life calculator.

Frequently asked questions

Does Wegovy make you more tired than Ozempic?

Not shown by the labels. Wegovy's label lists fatigue at 11% against 5% on placebo, while Ozempic's lists it among other reactions at a frequency above 0.4%, a reporting threshold rather than a fatigue rate. The doses and populations differ, so the two cannot be compared fairly.

Can low blood sugar cause tiredness on Mounjaro or Zepbound?

It can. Both labels warn that tirzepatide medicines can cause hypoglycemia, and Mounjaro's label says the risk rises with insulin or a sulfonylurea. Zepbound's label reports 4.2% against 1.3% on placebo in type 2 diabetes. Tiredness with shakiness, sweating or confusion should be raised with a prescriber.

Does fatigue mean the dose is too high?

The labels do not say so. Zepbound reports more fatigue at higher doses across groups, 7% at 15 mg against 5% at 5 mg, but that does not show a dose is wrong for one person. Whether to change a dose is a decision for you and your prescriber.

Does fatigue go away on its own?

The labels do not say. None gives a duration for fatigue, so no source here can promise that it fades. If tiredness continues, gets worse or comes with warning signs, tell your prescriber rather than waiting to see.

Sources

• Zepbound prescribing information, DailyMed: fatigue by dose, common reactions, hypoglycemia warning and rate.
• Wegovy prescribing information, DailyMed: fatigue against placebo, hypoglycemia warning and rate.
• Mounjaro prescribing information, DailyMed: fatigue absent from the main table, outcomes-trial figure, hypoglycemia warning.
• Ozempic prescribing information, DailyMed: fatigue absent from the main table, hypoglycemia rates with sulfonylurea or insulin, kidney injury warning.

Published by Petros IT Solutions SRL. Written by the Dose & Lose Editorial Team. Corrections: office@doseandlose.com.